A Study of Effectiveness and Safety of Apidra in Combination With Lantus Therapy in Basal-bolus Insulin Regimen in Inadequately Controlled Children and Adolescents With Type 1 Diabetes in the Russian Federation.
Phase of Trial: Phase IV
Latest Information Update: 17 Dec 2012
At a glance
- Drugs Insulin glulisine (Primary) ; Insulin glargine
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Sanofi
- 10 Jun 2017 Biomarkers information updated
- 01 Oct 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 08 Dec 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.